Concepts (283)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stroke | 23 | 2024 | 585 | 3.300 |
Why?
|
| Diabetes Mellitus | 6 | 2024 | 410 | 1.510 |
Why?
|
| Low Back Pain | 7 | 2022 | 45 | 1.340 |
Why?
|
| Automobile Driving | 5 | 2023 | 24 | 1.250 |
Why?
|
| Hypertension | 7 | 2023 | 972 | 1.110 |
Why?
|
| Accidents, Traffic | 6 | 2023 | 195 | 1.030 |
Why?
|
| Humans | 79 | 2024 | 32297 | 0.930 |
Why?
|
| Licensure | 4 | 2023 | 4 | 0.920 |
Why?
|
| Health Status Disparities | 6 | 2023 | 124 | 0.890 |
Why?
|
| United States | 26 | 2024 | 3983 | 0.840 |
Why?
|
| Medicare | 1 | 2024 | 206 | 0.830 |
Why?
|
| Risk Factors | 21 | 2024 | 3876 | 0.720 |
Why?
|
| Female | 50 | 2024 | 20126 | 0.690 |
Why?
|
| Adult | 29 | 2024 | 9467 | 0.620 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2019 | 121 | 0.600 |
Why?
|
| Cohort Studies | 13 | 2024 | 1832 | 0.600 |
Why?
|
| Aged | 25 | 2024 | 10398 | 0.590 |
Why?
|
| Incidence | 13 | 2024 | 1207 | 0.590 |
Why?
|
| Social Class | 7 | 2023 | 89 | 0.580 |
Why?
|
| Diabetes Mellitus, Type 2 | 5 | 2024 | 1428 | 0.580 |
Why?
|
| Male | 39 | 2024 | 19488 | 0.580 |
Why?
|
| Substance-Related Disorders | 4 | 2020 | 124 | 0.550 |
Why?
|
| Dental Hygienists | 1 | 2014 | 1 | 0.500 |
Why?
|
| Epidemiologic Research Design | 1 | 2014 | 5 | 0.500 |
Why?
|
| Unsafe Sex | 1 | 2014 | 24 | 0.490 |
Why?
|
| C-Reactive Protein | 3 | 2021 | 238 | 0.490 |
Why?
|
| Longitudinal Studies | 12 | 2023 | 786 | 0.470 |
Why?
|
| Public Health | 1 | 2014 | 83 | 0.460 |
Why?
|
| Middle Aged | 24 | 2024 | 11949 | 0.460 |
Why?
|
| Wounds and Injuries | 1 | 2016 | 267 | 0.450 |
Why?
|
| Cardiovascular Diseases | 5 | 2022 | 1133 | 0.440 |
Why?
|
| Students | 1 | 2014 | 175 | 0.440 |
Why?
|
| Protein Precursors | 2 | 2024 | 22 | 0.440 |
Why?
|
| Attitude of Health Personnel | 1 | 2014 | 182 | 0.440 |
Why?
|
| Child Restraint Systems | 2 | 2021 | 3 | 0.380 |
Why?
|
| Models, Statistical | 3 | 2023 | 176 | 0.380 |
Why?
|
| Coronary Disease | 3 | 2022 | 215 | 0.370 |
Why?
|
| Analgesics, Opioid | 3 | 2020 | 262 | 0.360 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2024 | 293 | 0.350 |
Why?
|
| Dental Caries | 3 | 2019 | 22 | 0.350 |
Why?
|
| HIV Infections | 1 | 2014 | 388 | 0.340 |
Why?
|
| Fertility | 3 | 2013 | 37 | 0.320 |
Why?
|
| Rural Population | 2 | 2023 | 274 | 0.320 |
Why?
|
| Poisson Distribution | 3 | 2023 | 17 | 0.320 |
Why?
|
| Residence Characteristics | 4 | 2022 | 190 | 0.320 |
Why?
|
| DMF Index | 3 | 2019 | 6 | 0.320 |
Why?
|
| Prospective Studies | 9 | 2024 | 2274 | 0.280 |
Why?
|
| Computer Simulation | 5 | 2023 | 220 | 0.280 |
Why?
|
| Child | 10 | 2024 | 2472 | 0.270 |
Why?
|
| Socioeconomic Factors | 6 | 2023 | 422 | 0.270 |
Why?
|
| Enkephalins | 2 | 2024 | 12 | 0.260 |
Why?
|
| Regression Analysis | 2 | 2016 | 296 | 0.250 |
Why?
|
| Mental Health | 2 | 2023 | 113 | 0.250 |
Why?
|
| Diet | 6 | 2023 | 384 | 0.250 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2024 | 30 | 0.230 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2024 | 60 | 0.230 |
Why?
|
| Ovulation Detection | 2 | 2013 | 2 | 0.220 |
Why?
|
| Independent Living | 1 | 2024 | 98 | 0.220 |
Why?
|
| Sleep | 2 | 2021 | 93 | 0.220 |
Why?
|
| Pregnancy | 8 | 2021 | 1010 | 0.220 |
Why?
|
| Health Behavior | 2 | 2021 | 229 | 0.210 |
Why?
|
| Activities of Daily Living | 1 | 2024 | 258 | 0.210 |
Why?
|
| Hypoglycemic Agents | 1 | 2024 | 188 | 0.210 |
Why?
|
| Neuropeptides | 1 | 2022 | 19 | 0.210 |
Why?
|
| Air Pollution | 1 | 2021 | 18 | 0.200 |
Why?
|
| Air Pollutants | 1 | 2021 | 21 | 0.200 |
Why?
|
| Retrospective Studies | 4 | 2024 | 3514 | 0.200 |
Why?
|
| Peptide Fragments | 2 | 2022 | 422 | 0.190 |
Why?
|
| Sex Factors | 5 | 2021 | 674 | 0.190 |
Why?
|
| Firearms | 1 | 2021 | 8 | 0.190 |
Why?
|
| Seat Belts | 1 | 2021 | 17 | 0.190 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2021 | 65 | 0.190 |
Why?
|
| Geography | 4 | 2021 | 35 | 0.190 |
Why?
|
| Adolescent | 6 | 2023 | 3571 | 0.190 |
Why?
|
| Sports | 1 | 2021 | 35 | 0.180 |
Why?
|
| Aggression | 1 | 2020 | 30 | 0.180 |
Why?
|
| Soccer | 1 | 2020 | 19 | 0.180 |
Why?
|
| Depression | 2 | 2022 | 436 | 0.180 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2020 | 36 | 0.180 |
Why?
|
| Sex Characteristics | 1 | 2020 | 176 | 0.170 |
Why?
|
| Pregnancy Complications | 2 | 2017 | 107 | 0.170 |
Why?
|
| Cognition Disorders | 1 | 2023 | 383 | 0.170 |
Why?
|
| Athletic Injuries | 1 | 2020 | 81 | 0.170 |
Why?
|
| Area Under Curve | 1 | 2019 | 95 | 0.170 |
Why?
|
| Selection Bias | 1 | 2019 | 14 | 0.170 |
Why?
|
| Algorithms | 1 | 2022 | 497 | 0.160 |
Why?
|
| Blood Glucose | 1 | 2021 | 496 | 0.160 |
Why?
|
| Dyslipidemias | 1 | 2019 | 53 | 0.160 |
Why?
|
| Cholesterol, HDL | 1 | 2019 | 176 | 0.160 |
Why?
|
| Quality of Life | 1 | 2024 | 915 | 0.150 |
Why?
|
| Substance Abuse Detection | 1 | 2017 | 8 | 0.150 |
Why?
|
| Narcotics | 1 | 2017 | 19 | 0.150 |
Why?
|
| Heart Failure | 1 | 2024 | 630 | 0.150 |
Why?
|
| Case-Control Studies | 4 | 2023 | 911 | 0.150 |
Why?
|
| Pain Measurement | 4 | 2022 | 370 | 0.150 |
Why?
|
| Cholesterol, LDL | 1 | 2018 | 172 | 0.150 |
Why?
|
| Odds Ratio | 1 | 2019 | 480 | 0.150 |
Why?
|
| Prevalence | 4 | 2023 | 986 | 0.150 |
Why?
|
| Dietary Sucrose | 1 | 2017 | 12 | 0.150 |
Why?
|
| Cocaine | 2 | 2017 | 270 | 0.150 |
Why?
|
| Risk Reduction Behavior | 1 | 2017 | 124 | 0.140 |
Why?
|
| Bicycling | 1 | 2016 | 14 | 0.140 |
Why?
|
| Placenta Previa | 1 | 2016 | 2 | 0.140 |
Why?
|
| Fetal Membranes, Premature Rupture | 1 | 2016 | 13 | 0.140 |
Why?
|
| Neonatal Abstinence Syndrome | 1 | 2016 | 1 | 0.140 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2016 | 13 | 0.140 |
Why?
|
| Exercise | 4 | 2023 | 655 | 0.140 |
Why?
|
| Binomial Distribution | 1 | 2015 | 2 | 0.130 |
Why?
|
| Delivery, Obstetric | 1 | 2016 | 58 | 0.130 |
Why?
|
| Antihypertensive Agents | 1 | 2019 | 362 | 0.130 |
Why?
|
| Risk Assessment | 5 | 2021 | 1447 | 0.130 |
Why?
|
| Accidents | 1 | 2015 | 5 | 0.130 |
Why?
|
| Benzodiazepines | 1 | 2015 | 9 | 0.130 |
Why?
|
| Young Adult | 4 | 2016 | 2626 | 0.130 |
Why?
|
| Premature Birth | 1 | 2016 | 66 | 0.130 |
Why?
|
| Dentin | 1 | 2014 | 1 | 0.130 |
Why?
|
| Calcium Hydroxide | 1 | 2014 | 2 | 0.130 |
Why?
|
| Root Canal Filling Materials | 1 | 2014 | 2 | 0.130 |
Why?
|
| Silicates | 1 | 2014 | 2 | 0.130 |
Why?
|
| Aluminum Compounds | 1 | 2014 | 3 | 0.130 |
Why?
|
| Calcium Compounds | 1 | 2014 | 8 | 0.130 |
Why?
|
| Dental Care for Aged | 1 | 2014 | 6 | 0.130 |
Why?
|
| Stereotyping | 1 | 2014 | 9 | 0.130 |
Why?
|
| Oxides | 1 | 2014 | 15 | 0.120 |
Why?
|
| Lead | 1 | 2014 | 6 | 0.120 |
Why?
|
| Aged, 80 and over | 5 | 2024 | 4050 | 0.120 |
Why?
|
| Homes for the Aged | 1 | 2014 | 20 | 0.120 |
Why?
|
| Harm Reduction | 1 | 2014 | 14 | 0.120 |
Why?
|
| Likelihood Functions | 1 | 2014 | 48 | 0.120 |
Why?
|
| Nursing Homes | 1 | 2014 | 43 | 0.120 |
Why?
|
| Opioid-Related Disorders | 1 | 2015 | 56 | 0.120 |
Why?
|
| Inflammation | 3 | 2022 | 542 | 0.120 |
Why?
|
| Cervix Mucus | 1 | 2013 | 1 | 0.110 |
Why?
|
| West Virginia | 3 | 2020 | 15 | 0.110 |
Why?
|
| Parents | 3 | 2023 | 150 | 0.110 |
Why?
|
| Follicle Stimulating Hormone, Human | 1 | 2012 | 1 | 0.110 |
Why?
|
| Cross-Sectional Studies | 3 | 2024 | 1522 | 0.110 |
Why?
|
| Lubricants | 1 | 2012 | 1 | 0.110 |
Why?
|
| Proportional Hazards Models | 3 | 2022 | 759 | 0.110 |
Why?
|
| Albuminuria | 2 | 2024 | 181 | 0.100 |
Why?
|
| Self Care | 1 | 2013 | 145 | 0.100 |
Why?
|
| Age Factors | 3 | 2020 | 1204 | 0.100 |
Why?
|
| Models, Biological | 1 | 2014 | 397 | 0.100 |
Why?
|
| Vagina | 1 | 2012 | 58 | 0.100 |
Why?
|
| Body Mass Index | 3 | 2020 | 921 | 0.100 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2011 | 7 | 0.100 |
Why?
|
| Pregnancy Proteins | 1 | 2011 | 13 | 0.100 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2011 | 23 | 0.100 |
Why?
|
| Neoplasms | 1 | 2019 | 695 | 0.100 |
Why?
|
| Molar, Third | 1 | 2011 | 2 | 0.100 |
Why?
|
| Tooth Extraction | 1 | 2011 | 18 | 0.100 |
Why?
|
| Minocycline | 1 | 2011 | 11 | 0.100 |
Why?
|
| Cryotherapy | 1 | 2011 | 13 | 0.100 |
Why?
|
| Time Factors | 4 | 2020 | 2181 | 0.100 |
Why?
|
| Pre-Eclampsia | 1 | 2011 | 69 | 0.090 |
Why?
|
| Child, Preschool | 3 | 2021 | 1281 | 0.090 |
Why?
|
| Alabama | 2 | 2021 | 42 | 0.090 |
Why?
|
| Infant, Newborn | 3 | 2017 | 681 | 0.090 |
Why?
|
| Vitamin D | 1 | 2011 | 186 | 0.090 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2013 | 353 | 0.090 |
Why?
|
| Pain, Postoperative | 1 | 2011 | 178 | 0.080 |
Why?
|
| Anti-Bacterial Agents | 1 | 2011 | 309 | 0.080 |
Why?
|
| Forensic Toxicology | 2 | 2020 | 3 | 0.080 |
Why?
|
| Cognition | 2 | 2023 | 551 | 0.080 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2021 | 511 | 0.070 |
Why?
|
| Logistic Models | 2 | 2021 | 788 | 0.070 |
Why?
|
| Dental Caries Susceptibility | 2 | 2017 | 2 | 0.070 |
Why?
|
| Educational Status | 2 | 2018 | 177 | 0.070 |
Why?
|
| Predictive Value of Tests | 3 | 2013 | 877 | 0.070 |
Why?
|
| Reproducibility of Results | 2 | 2021 | 779 | 0.060 |
Why?
|
| Infant | 2 | 2019 | 1076 | 0.060 |
Why?
|
| Snoring | 1 | 2024 | 10 | 0.060 |
Why?
|
| Transportation | 1 | 2023 | 13 | 0.060 |
Why?
|
| Population Dynamics | 1 | 2023 | 6 | 0.060 |
Why?
|
| Leisure Activities | 1 | 2023 | 13 | 0.060 |
Why?
|
| Cardiovascular System | 1 | 2023 | 45 | 0.060 |
Why?
|
| Cholinergic Antagonists | 1 | 2023 | 12 | 0.060 |
Why?
|
| Social Environment | 1 | 2023 | 80 | 0.060 |
Why?
|
| Interleukin-6 | 1 | 2024 | 248 | 0.050 |
Why?
|
| Ambulatory Care Facilities | 1 | 2023 | 83 | 0.050 |
Why?
|
| Monte Carlo Method | 1 | 2022 | 19 | 0.050 |
Why?
|
| Censuses | 1 | 2022 | 10 | 0.050 |
Why?
|
| Guanosine | 1 | 2022 | 1 | 0.050 |
Why?
|
| Pseudouridine | 1 | 2022 | 1 | 0.050 |
Why?
|
| Neurotensin | 1 | 2022 | 5 | 0.050 |
Why?
|
| Nucleosides | 1 | 2022 | 10 | 0.050 |
Why?
|
| Bayes Theorem | 1 | 2022 | 78 | 0.050 |
Why?
|
| Cities | 1 | 2021 | 6 | 0.050 |
Why?
|
| Sequence Analysis, DNA | 1 | 2022 | 136 | 0.050 |
Why?
|
| Glomerular Filtration Rate | 1 | 2023 | 309 | 0.050 |
Why?
|
| Particulate Matter | 1 | 2021 | 31 | 0.050 |
Why?
|
| Follow-Up Studies | 2 | 2017 | 2296 | 0.050 |
Why?
|
| Stress, Psychological | 1 | 2023 | 218 | 0.050 |
Why?
|
| Glucose | 1 | 2022 | 177 | 0.050 |
Why?
|
| Food Supply | 1 | 2022 | 62 | 0.050 |
Why?
|
| Hemoglobin, Sickle | 1 | 2021 | 8 | 0.050 |
Why?
|
| Income | 1 | 2021 | 60 | 0.050 |
Why?
|
| Epigenesis, Genetic | 1 | 2022 | 104 | 0.050 |
Why?
|
| Movement | 1 | 2021 | 49 | 0.050 |
Why?
|
| Child Behavior | 1 | 2021 | 27 | 0.050 |
Why?
|
| Pain Threshold | 1 | 2021 | 95 | 0.050 |
Why?
|
| Environmental Exposure | 1 | 2021 | 92 | 0.050 |
Why?
|
| DNA Methylation | 1 | 2022 | 142 | 0.050 |
Why?
|
| Neuropsychological Tests | 1 | 2022 | 379 | 0.050 |
Why?
|
| Feasibility Studies | 1 | 2021 | 294 | 0.050 |
Why?
|
| Coroners and Medical Examiners | 1 | 2020 | 6 | 0.050 |
Why?
|
| Lumbar Vertebrae | 1 | 2021 | 98 | 0.050 |
Why?
|
| Cross-Over Studies | 1 | 2020 | 101 | 0.050 |
Why?
|
| Video Recording | 1 | 2020 | 57 | 0.050 |
Why?
|
| Parenting | 1 | 2020 | 23 | 0.050 |
Why?
|
| Life Style | 1 | 2022 | 404 | 0.040 |
Why?
|
| Lung Diseases | 1 | 2020 | 50 | 0.040 |
Why?
|
| Sex Distribution | 1 | 2020 | 201 | 0.040 |
Why?
|
| Genome-Wide Association Study | 1 | 2022 | 560 | 0.040 |
Why?
|
| Age Distribution | 1 | 2020 | 210 | 0.040 |
Why?
|
| Disability Evaluation | 1 | 2020 | 236 | 0.040 |
Why?
|
| Central Nervous System Stimulants | 1 | 2020 | 75 | 0.040 |
Why?
|
| Emergency Service, Hospital | 1 | 2023 | 463 | 0.040 |
Why?
|
| Physicians, Family | 1 | 2019 | 16 | 0.040 |
Why?
|
| Linear Models | 1 | 2020 | 454 | 0.040 |
Why?
|
| Lipids | 1 | 2020 | 226 | 0.040 |
Why?
|
| Waist Circumference | 1 | 2018 | 91 | 0.040 |
Why?
|
| American Heart Association | 1 | 2019 | 89 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2019 | 144 | 0.040 |
Why?
|
| Comorbidity | 1 | 2020 | 572 | 0.040 |
Why?
|
| Opiate Alkaloids | 1 | 2017 | 1 | 0.040 |
Why?
|
| Meconium | 1 | 2017 | 2 | 0.040 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2017 | 6 | 0.040 |
Why?
|
| Biological Assay | 1 | 2017 | 19 | 0.040 |
Why?
|
| Cause of Death | 1 | 2019 | 244 | 0.040 |
Why?
|
| Cardiology | 1 | 2019 | 91 | 0.040 |
Why?
|
| Dentifrices | 1 | 2017 | 1 | 0.040 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2017 | 90 | 0.040 |
Why?
|
| Random Allocation | 1 | 2017 | 220 | 0.040 |
Why?
|
| Mortality | 1 | 2017 | 126 | 0.030 |
Why?
|
| Obesity | 1 | 2024 | 1164 | 0.030 |
Why?
|
| Hallucinogens | 1 | 2016 | 12 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2017 | 600 | 0.030 |
Why?
|
| Mouthwashes | 1 | 2015 | 3 | 0.030 |
Why?
|
| Fluorides, Topical | 1 | 2015 | 6 | 0.030 |
Why?
|
| Gestational Age | 1 | 2016 | 122 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 410 | 0.030 |
Why?
|
| Alcohol Drinking | 1 | 2018 | 257 | 0.030 |
Why?
|
| Blood Pressure | 1 | 2020 | 859 | 0.030 |
Why?
|
| Learning | 1 | 2016 | 79 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2016 | 302 | 0.030 |
Why?
|
| Aging | 1 | 2022 | 953 | 0.030 |
Why?
|
| Powders | 1 | 2014 | 8 | 0.030 |
Why?
|
| Tooth, Deciduous | 1 | 2014 | 3 | 0.030 |
Why?
|
| Research Design | 1 | 2017 | 313 | 0.030 |
Why?
|
| Rheology | 1 | 2014 | 30 | 0.030 |
Why?
|
| Particle Size | 1 | 2014 | 45 | 0.030 |
Why?
|
| Urban Health | 1 | 2014 | 14 | 0.030 |
Why?
|
| Dental Care | 1 | 2014 | 18 | 0.030 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2014 | 99 | 0.030 |
Why?
|
| Drug Combinations | 1 | 2014 | 93 | 0.030 |
Why?
|
| Birth Weight | 1 | 2014 | 46 | 0.030 |
Why?
|
| Materials Testing | 1 | 2014 | 84 | 0.030 |
Why?
|
| Length of Stay | 1 | 2016 | 315 | 0.030 |
Why?
|
| Breast Feeding | 1 | 2014 | 43 | 0.030 |
Why?
|
| Mexican Americans | 1 | 2014 | 60 | 0.030 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2014 | 41 | 0.030 |
Why?
|
| Poverty | 1 | 2014 | 111 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2015 | 355 | 0.030 |
Why?
|
| Fertilization | 1 | 2013 | 6 | 0.030 |
Why?
|
| Nutrition Surveys | 1 | 2014 | 149 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2014 | 244 | 0.030 |
Why?
|
| Attitude to Health | 1 | 2014 | 167 | 0.030 |
Why?
|
| Nonlinear Dynamics | 1 | 2012 | 51 | 0.030 |
Why?
|
| Administration, Intravaginal | 1 | 2012 | 8 | 0.030 |
Why?
|
| Pregnancy Rate | 1 | 2012 | 11 | 0.030 |
Why?
|
| Atherosclerosis | 1 | 2019 | 770 | 0.030 |
Why?
|
| Creatinine | 1 | 2012 | 200 | 0.030 |
Why?
|
| ROC Curve | 1 | 2011 | 171 | 0.020 |
Why?
|
| Mandible | 1 | 2011 | 39 | 0.020 |
Why?
|
| Genetic Testing | 1 | 2011 | 99 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2011 | 110 | 0.020 |
Why?
|
| Administration, Topical | 1 | 2011 | 140 | 0.020 |
Why?
|
| Osteotomy | 1 | 2011 | 51 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2012 | 696 | 0.020 |
Why?
|
| Analgesics | 1 | 2011 | 127 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2011 | 567 | 0.020 |
Why?
|
| North Carolina | 1 | 2012 | 1520 | 0.020 |
Why?
|